Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study.

However, regular use of anti-TNF therapy was more common among patients who started anti-TNF therapy at > 24 months after diagnosis than among those who started such therapy early, although the difference did not reach statistical significance.

also in 111,027 other papers